Part,  Chapter, Paragraph

 1   II,     9.  1.  1|    Roosmalen J, Schuitemaker NW, Brand R, van Dongen PW, Bennebroek
 2   II,     9.  3.  2|    Roosmalen J, Schuitemaker NW, Brand R, van Dongen PW, Bennebroek
 3  III,    10.  2.  4|       and therapy (Khoury, 1996; Brand, 2002; French and Moore
 4  III,    10.  2.  4|    organised efforts of society (Brand, 2005). Policymakers now
 5  III,    10.  2.  4|      disease and improve health (Brand et al., 2006). Policy must
 6  III,    10.  2.  4|           10.2.4.6. References~ ~Brand A (2002): Prädiktive Gentests –
 7  III,    10.  2.  4| Gesundheitswesen, 64: 224-229.~ ~Brand A (2005): Public health
 8  III,    10.  2.  4|         Health, 15(2):114-116.~ ~Brand A, Schröder P, Brand H,
 9  III,    10.  2.  4|             Brand A, Schröder P, Brand H, Zimmern R (2006): Getting
10  III,    10.  6.  1|        GA, Salonen JT, Cohen RD, Brand RJ, Syme SL, Puska P (1988).
11   IV,    11.  3.  2|      expensive generic drugs for brand name drugs once the pharmaceutical
12   IV,    11.  3.  2|         and only if the original brand is not available, in the